During the past decade, Toledo Clinic Cancer Centers-Toledo conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 95 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 53 clinical trials were completed. i.e. 120.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toledo Clinic Cancer Centers-Toledo" #1 sponsor was "National Cancer Institute (NCI)" with 95 trials, followed by "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored and "Academic and Community Cancer Research United" with 14 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toledo Clinic Cancer Centers-Toledo" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Toledo Clinic Cancer Centers-Toledo" are "Recurrent Breast Carcinoma" (10 trials), "Stage IV Breast Cancer AJCC v6 and v7" (7 trials), "HER2/Neu Negative" (6 trials), "Invasive Breast Carcinoma" (6 trials) and "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Toledo Clinic Cancer Centers-Toledo" in a lesser frequency.

Most popular intervention types in "Toledo Clinic Cancer Centers-Toledo" are "Drug" (176 trials), "Other" (111 trials), "Biological" (86 trials), "Procedure" (38 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (62 trials), "Quality-of-Life Assessment" (46 trials), "Biospecimen Collection" (21 trials), "Computed Tomography" (21 trials) and "Questionnaire Administration" (21 trials). Other intervention names were less common.

The vast majority of trials in "Toledo Clinic Cancer Centers-Toledo" are 170 trials for "All" genders, 18 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Toledo Clinic Cancer Centers-Toledo". undefined are not yet recruiting, 45 are recruiting, 84 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Toledo Clinic Cancer Centers-Toledo, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Toledo Clinic Cancer Centers-Toledo, 11 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 106 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".